Entrectinib
Entrectinib
Entrectinib targets HASPIN, NTRK2, RET.
Top hallmarks
No hallmark data.Top pathways disrupted
Resistance landscape — Entrectinib
10 known oncogenic variants exist on Entrectinib's top targets — see detail for inhibition impact.